COMMON TRANSCRIPTIONAL PROGRAMS AND THE ROLE OF CHEMOKINE (C-C MOTIF) LIGAND 20 (CCL20) IN CELL MIGRATION OF CHOLANGIOCARCINOMA

被引:3
|
作者
Maung, Hay Mar Win [1 ]
Chan-On, Waraporn [2 ]
Kunkeaw, Nawapol [3 ]
Khaenam, Prasong [1 ]
机构
[1] Mahidol Univ, Fac Med Technol, Ctr Standardizat & Prod Validat, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
[2] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
[3] Mahidol Univ, Inst Mol Biosci, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
来源
EXCLI JOURNAL | 2020年 / 19卷
关键词
CCL20; CCR6; cholangiocarcinoma (CCA); microarray; epithelial-mesenchymal transition (EMT); cell migration; EPITHELIAL-MESENCHYMAL TRANSITION; EXPRESSION; CANCER; CCR6; PROLIFERATION;
D O I
10.17179/excli2019-1893
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The incidence of cholangiocarcinoma (CCA) has risen in many countries, but there is still no appropriate screening and treatment available. The growing number of microarray data published todays can be a powerful resource for the discovery of biomarkers to tackle challenges in the management of CCA. This study analyzed multiple microarray datasets to identify the common transcriptional networks in CCA and select a possible biomarker for functional study in CCA cell lines. A systematic searching identified 4 microarray datasets from Gene Expression Omnibus (GEO) repository and PubMed articles.Differential expression analysis between tumor and normal tissues was performed in each dataset. In order to characterize the common expression pattern, differentially expressed genes (DEGs) from all datasets were combined and visualized by hierarchical clustering and heatmap. Gene enrichment analysis performed in each cluster revealed that over-expressed DEGs were enriched in cell cycle, cell migration and response to cytokines while under-expressed DEGs were enriched in metabolic processes such as oxidation-reduction, lipid, and drug. To explain tumor characteristics, genes enriched in cell migration and response to cytokines were further investigated. Among these genes, CCL20 was selected for functional study because its role has never been studied in CCA. Moreover, its signaling may be regulated by disrupting its only receptor, CCR6. Treatment with recombinant CCL20 induced higher cell migration and increased expression of N-cad. In contrast, knockdown of CCR6 by siRNA reduced cell migration ability and decreased N-cadherin level. Altogether, these results suggested the contribution of CCL20/CCR6 signaling in cell migration through epithelialmesenchymal transition process. Thus, CCL20/CCR6 signaling might be a target for the management of CCA.
引用
收藏
页码:154 / 166
页数:13
相关论文
共 50 条
  • [1] Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
    Kwantwi, Louis Boafo
    Wang, Shujing
    Sheng, Youjing
    Wu, Qiang
    BIOENGINEERED, 2021, 12 (01) : 6923 - 6934
  • [2] C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release
    Skovdahl, Helene Kolstad
    Damas, Jan Kristian
    Granlund, Atle van Beelen
    Ostvik, Ann Elisabet
    Doseth, Berit
    Bruland, Torunn
    Mollnes, Tom Eirik
    Sandvik, Arne Kristian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [3] Role of C-C Motif Chemokine Ligand 20 in the Regulation of Epidermal γδ T Cells
    Bshara-Corson, Savannah
    Gonzalez, Isaac
    Jameson, Julie M.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [4] Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia
    Lin, Sensen
    Wan, Shuying
    Sun, Li
    Hu, Jialiang
    Fang, Dongdong
    Zhao, Renping
    Yuan, Shengtao
    Zhang, Luyong
    CANCER SCIENCE, 2012, 103 (05) : 904 - 912
  • [5] Chemokine (C-C Motif) Ligand 20, a Potential Biomarker for Graves' Disease, Is Regulated by Osteopontin
    Li, Xiaoli
    Qi, Yicheng
    Ma, Xinran
    Huang, Fengjiao
    Guo, Hua
    Jiang, Xiaohua
    Hong, Jie
    Lin, Dongping
    Cui, Bin
    Ning, Guang
    Xu, Lingyan
    Wang, Shu
    PLOS ONE, 2013, 8 (05):
  • [6] Chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 7 in angle-closure glaucoma
    Gao, Xinbo
    Huang, Wenbin
    Zhang, Xiulan
    Du, Shaolin
    Wang, Jiawei
    Wang, Wei
    Zhou, Minwen
    Chen, Shida
    Li, Xingyi
    Jonas, Jost B.
    ACTA OPHTHALMOLOGICA, 2016, 94 (03) : E220 - E224
  • [7] Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells
    Mita, Shizuka
    Nakakuki, Masanori
    Ichioka, Masayuki
    Shimizu, Yutaka
    Hashiba, Masamichi
    Miyazaki, Hiroyasu
    Kyo, Satoru
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 214 : 65 - 70
  • [8] INFLAMMATION AND METABOLISM: THE ROLE OF CHEMOKINE (C-C MOTIF) LIGAND 2
    Rodriguez-Gallego, E.
    Marine-Casado, R.
    Guirro, M.
    Hernandez-Aguilera, A.
    Luciano-Mateo, F.
    Cabre, N.
    Fernandez-Arroyo, S.
    Camps, J.
    Joven, J.
    ATHEROSCLEROSIS, 2015, 241 (01) : E63 - E63
  • [9] Role of C-C Motif Chemokine Ligand 2 in Metastatic Neuroblastoma
    Zobel, Michael J.
    Zamora, Abigail
    Asuelime, Grace
    Asgharzadeh, Shahab
    Kim, Eugene S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S217 - S217
  • [10] Expression of the C-C chemokine MIP-3α/CCL20 in human epidermis with impaired permeability barrier function
    Schmuth, M
    Neyer, S
    Rainer, C
    Grassegger, A
    Fritsch, P
    Romani, N
    Heufler, C
    EXPERIMENTAL DERMATOLOGY, 2002, 11 (02) : 135 - 142